Introduction {#Sec1}
============

Echocardiography (echo) constitutes initial diagnostic work-up of patients presenting with new onset heart failure \[[@CR1]\]. Further, echo helps to distinguish the pathological variants of cardiomyopathy \[[@CR1], [@CR2]\]. Patients with dilated cardiomyopathy and systolic dysfunction on echo often undergo non-invasive myocardial ischemic stress testing or invasive coronary angiogram to evaluate for coronary artery disease (CAD) as underlying etiology \[[@CR3]\]. Non-invasive tests to detect CAD such as stress myocardial perfusion imaging or cardiac computed tomography may not be able to distinguish ischemic vs. non-ischemic cardiomyopathy with high degree of confidence. An echocardiographic marker to diagnose ICM and facilitate appropriate patient selection before an invasive procedure would be desirable. Older studies have used regional wall motion abnormality (RWMA) assessment as a diagnostic marker for ICM with conflicting results \[[@CR4]--[@CR6]\]. Coronary obstruction not only affects segmental wall motion but also wall thickness, with infarcted or hibernating myocardial segments frequently appearing thinner compared to surrounding healthy myocardium. The diagnostic utility of segmental wall thickness on echo has not been systematically evaluated. The objectives of this study were to determine non-invasive markers (clinical, EKG and echo parameters) that would reliably distinguish ICM from non-ischemic cardiomyopathy (NICM) in patients with new onset heart failure. We specifically evaluated segmental thickness variability (STV) as a novel non-invasive diagnostic marker in the evaluation of ICM and evaluated its diagnostic performance compared to the gold standard of angiography.

Materials and methods {#Sec2}
=====================

We retrospectively identified one hundred consecutive patients over a period of 3 years (2011--2014) admitted to a single center for new-onset systolic heart failure, who had dilated cardiomyopathy on echo (dilated left ventricle with an ejection fraction less than 40%), and underwent angiographic evaluation for ICM. After excluding those with (1) known history of dilated cardiomyopathy; (2) previous diagnosis of heart failure (hospital admission, emergency room, or clinic visit); (3) previous diagnosis of CAD (history of stable angina pectoris, acute coronary syndrome, positive stress testing, obstructive CAD on angiography, coronary intervention, or coronary artery bypass surgery); (4) acute coronary syndrome presentation; and (5) missing echo or angiographic data; 118 patients were identified. Further, those with (6) severe primary valvular heart disease that could contribute to LV dilatation (n = 2); (7) non-dilated cardiomyopathy (hypertrophic and restrictive cardiomyopathies with normal LV size) (n = 9); and (8) poor quality echo images precluding accurate segmental wall thickness/wall motion assessment (n = 7) were excluded. A total of 100 patients were included in the final analysis.

A thorough review of electronic medical records was conducted to collect demographics information, co-morbidities, clinical presentation, laboratory markers, pre-hospital medications, ECG, and the echo parameters at baseline. Myocardial segmental analysis was confirmed by the consensus read of two National Board of Echocardiography certified cardiologists. Investigators collecting baseline data and reviewing echo were blinded to the results of angiography. A single investigator, who was not involved in data collection, had access to angiography results. On the completion of data collection, this investigator categorized the patients into two groups (ICM and NICM) for statistical analysis. ICM was defined as severe (≥ 70%) stenosis in the left anterior descending or a multi-vessel coronary distribution. NICM had no angiographic stenosis, mild to moderate coronary stenosis (\< 70% stenosis), or severe single-vessel stenosis in a coronary vessel other than the left main or left anterior descending artery \[[@CR7]\] Degree of angiographic stenosis was based on the angiographer's interpretation adjudicated by the study investigators.

American heart Association's sixteen-segment model was used for regional left ventricular (LV) wall analysis \[[@CR8]--[@CR10]\]. Basal, mid, and apical slices of the parasternal short-axis were used for segmental wall thickness analysis \[[@CR8]\]. Short axis views were obtained orthogonal to the long axis of the LV to avoid skewed measurements from oblique cuts. Papillary muscles and the right ventricular (RV) septal band were systematically excluded wherever possible. Segmental thickness variability (STV) was measured in end-diastole, on a per-patient basis, and defined as a ratio of thinnest to the thickest wall segment in a different coronary artery territory \[STV = thinnest wall segment (cm)/thickest wall segment (cm)\]. Based on this definition, no variability (equally thick walls) would ideally yield a ratio 1. Based on preliminary analysis of the ICM cases, a cut-off value of 0.65 was used to define significant STV (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}). Intra and inter-observer variability in the STV was estimated by two independent readers in 10 randomly selected subjects of ICM and 20 subjects of NICM.

Fig. 1A case of non-ischemic dilated cardiomyopathy presenting as new onset heart failure. Short axis view of the left ventricle demonstrating uniform myocardial segmental thickness (9 ± 1 mm) and segmental thickness variability (STV) of \> 0.65

Fig. 2A case of new onset heart failure from ischemic dilated cardiomyopathy. Short axis view of the left ventricle illustrating thinned inferior wall (3 mm) and relatively thicker other segments (septum; 7 mm, anterior wall; 7 mm; lateral wall; 8 mm) in end diastolic phase with a segmental thickness variability (STV) of \< 0.65

RWMA was defined as per American Society of Echocardiography guidelines; hypokinesis, akinesis, dyskinesis, and aneurysmal segments were considered abnormal \[[@CR8], [@CR11]\]. Isolated septal WMA in patients with RV pressure/volume overload, left bundle branch block, or ventricular pacing were not reported as WMA from ICM.

Cardiac chamber quantification and function was estimated per ASE guideline statement \[[@CR8]\]. Biplane measurements used to estimate LVEF. LV dilatation was defined as LV end diastolic diameter (2D echo − parasternal long axis view) \> 5.2 cm in females and \> 5.8 cm in males. In addition to visual estimation, RV size was measured by RV end diastolic basal diameter in RV---focused apical 4-chamber view. Tricuspid annular planar systolic excursion (TAPSE), tissue Doppler derived tricuspid lateral annular systolic velocity (S′) and 2D RV fractional area (FAC) change parameters were used to estimate RV systolic function.

Statistical analysis {#Sec3}
--------------------

Demographic, clinical, laboratory, ECG, and echo parameters were compared between the ICM and NICM groups. Continuous variables were reported as mean and standard deviation and discrete variables as percentage. Analysis of variance (ANOVA) and Chi square tests were used to compare these variables, respectively. A two-sided P-value less than 0.05 was considered statistically significant. Variables that were significantly different between the comparison groups were evaluated for their sensitivity, specificity, negative and positive predictive values, and diagnostic accuracy for the diagnosis of ICM with invasive coronary angiography as the gold standard. Receiver operating characteristic curve analysis was performed. The intra-class correlation coefficient (ICC) was calculated as a measure of the intra- and inter-observer variability of the STV. A P value \< 0.05 was considered significant.

SPSS 20 (IBM SPSS statistics for Windows version 20.0 Armonk, New York) was used for all statistical analysis.

Results {#Sec4}
=======

The mean age of the study population was 56 years with 68% males. Mean LV size and LV ejection fraction were 6.1 cm and 26%, respectively. A total of 24% had ICM confirmed by coronary angiogram. Patients with ICM were older (65 vs. 53 years) (Table [1](#Tab1){ref-type="table"}). As expected, hypertension, hyperlipidemia, diabetes, and stroke were more prevalent with ICM. None of the NICM patients had obstructive CAD. Alcoholism and illicit drug use were more common in the NICM group pointing towards other potential etiological mechanisms of heart failure. However, these differences in baseline comorbidities did not reach statistical significance and therefore were not used for diagnostic test evaluation. Clinical presentation of the two groups was not statistically different either. Patients with ICM had less favorable lipid profile with higher total cholesterol and low-density lipoprotein levels. They had statistically higher mean troponin but similar BNP levels on presentation. They were more likely to be on antiplatelet agents and statin medications. ECG parameters showed no statistical differences.

Table 1Baseline characteristics of patients with new onset heart failure and dilated cardiomyopathy on echocardiographyNon-ischemic dilated cardiomyopathy (n = 76)Ischemic cardiomyopathy (n = 24)P valueAge (years)53.20 ± 14.4365.17 ± 11.46\< 0.001Male51 (67.11)17 (70.83)0.086Ethnicity Caucasian11 (14.47)5 (20.83)0.456 Hispanic38 (50.00)7 (29.17) African-American8 (10.53)4 (16.67) Other5 (6.58)3 (12.5) Unknown14 (18.42)5 (20.83)Body mass index29.26 ± 7.0627.90 ± 5.900.392Clinical presentation Shortness of breath/orthopnea/PND59 (77.63)23 (95.83)0.064 Chest pain26 (34.21)12 (50.00)0.228 Edema/weight gain40 (52.63)9 (37.50)0.244 Duration of symptoms (days)18.88 ± 26.4317.46 ± 27.930.821 Atrial fibrillation at presentation9 (11.84)3 (12.50)1.000 Heart rate at presentation101.65 ± 19.9298.83 ± 24.090.568 Systolic blood pressure at presentation144.61 ± 27.84136.75 ± 25.940.224 Diastolic blood pressure at presentation93.72 ± 18.3784.67 ± 20.430.043Co-morbidities Hypertension51 (67.11)20 (83.33)0.196 Hyperlipidemia18 (23.68)9 (37.50)0.197 Diabetes mellitus30 (39.47)14 (58.33)0.156 Chronic kidney disease7 (9.21)1 (4.17)0.676 Chronic obstructive pulmonary disease7 (9.21)1 (4.17)0.676 Stroke/transient ischemic attack6 (7.89)4 (16.67)0.246 Peripheral vascular disease2 (2.63)1 (4.17)0.565 Smoking33 (43.42)7 (29.17)0.241 Alcoholism17 (22.37)4 (16.67)0.775 Substance abuse21 (27.63)4 (16.67)0.418Laboratory markers Total cholesterol137.20 ± 35.05152.77 ± 43.230.095 Triglycerides99.47 ± 53.72105.82 ± 56.610.638 High density lipoprotein36.36 ± 15.1037.46 ± 12.330.760 Low density lipoprotein81.09 ± 25.6694.14 ± 33.680.062 BNP1503.09 ± 1555.801284.33 ± 1207.510.556 Peak troponin0.12 ± 0.210.83 ± 1.18\< 0.001 Hemoglobin A1C6.99 ± 1.997.32 ± 2.140.526Medications Aspirin23 (30.26)14 (58.33)0.013 P2Y12 inhibitors1 (1.32)4 (16.67)0.011 Beta-blockers23 (30.26)10 (41.67)0.327 Angiotensin converting enzyme-inhibitors19 (25.00)13 (54.17)0.012 Angiotensin receptor blockers6 (7.89)2 (8.33)1.000 Thiazides5 (6.58)2 (8.33)0.672 Calcium channel blockers4 (5.26)2 (8.33)0.628 Other anti-hypertensive medications10 (13.16)3 (12.50)1.000 Insulin15 (19.74)4 (16.67)1.000 Oral hypoglycemic agents9 (11.84)5 (20.83)0.314 Statins15 (19.74)12 (50.00)0.007EKG parameters Q waves9 (12.00)5 (20.83)0.318 QRS duration110.56 ± 22.80116.17 ± 27.800.323 Poor R-wave progression35 (46.67)12 (50.00)0.818 Left bundle branch block5 (6.67)1 (4.17)1.000 Right bundle branch block8 (10.67)4 (16.67)0.477 Non-specific IVCD12 (16.00)8 (33.33)0.082Echo parameters Left ventricular ejection fraction (%)25.61 ± 6.9026.04 ± 7.770.797Diastolic dysfunction Grade 19/74 (12.16)1 (4.35)0.443 Grade 2--358/74 (78.38)19 (82.61)0.775 Left ventricular cavity size in diastole (cm)6.10 ± 0.905.9817 ± 0.810.559 Left atrial diameter (cm)4.62 ± 0.844.36 ± 0.470.146 Mean segmental thickness variability^a^0.89 ± 0.080.63 ± 0.15\< 0.001 Segmental thickness variability1 (1.32)19 (79.17)\< 0.001 Regional wall motion abnormality12 (15.79)16 (66.67)\< 0.001 Right ventricular enlargement29 (38.16)3 (12.50)0.023 Right ventricular dysfunction36 (47.37)9 (37.50)0.483 RV systolic pressure41.86 ± 13.8139.44 ± 16.020.526 Ventricular thrombus4 (5.26)4 (16.67)0.092Mitral regurgitation Mild46 (60.53)16 (66.67)0.638 Moderate to severe17 (22.37)6 (25.00)0.786Mechanism for moderate to severe mitral regurgitation Annular dilatation5/15 (33.33)5/6 (83.33)0.063 Restrictive leaflet motion10/15 (66.67)1/6 (16.67) Pericardial effusion18 (23.68)8/24 (33.33)0.424*PND* paroxysmal nocturnal dyspnea, *IVCD* intra-ventricular conduction delay^a^Segmental thickness variability (%) = thinnest wall segment (cm)/thickest wall segment (cm)

Mean LV dimensions and systolic function was comparable between the two groups. Similarly, diastolic function and LA dimensions did not provide significant distinction. RV enlargement was more frequently seen in NICM patients (38 vs. 13%; P = 0.023) but RV systolic function and RV systolic pressures were similar. Using the pre-specified cut-off, significant STV was observed in 79% of ICM (mean STV 63%) and only 1% of NICM (mean STV 89%) (P \< 0.001). ICM patients also had more RWMA than NICM patients (67 vs. 16%; P \< 0.001).

Diagnostic test evaluations for STV, RWMA, and RV enlargement are elaborated in Table [2](#Tab2){ref-type="table"}. STV outperformed RWMA and RV size in diagnosing ICM with a sensitivity and specificity of 79.2% and 98.7%. RWMA was more specific (84.2%) than sensitive (66.7%). The most sensitive (91.7%) way of identifying ICM on echo was to use the presence of either STV or RWMA (negative predictive value 96.9%) as a diagnostic marker. On the other hand, the presence of both STV and RWMA made the test 100% specific for ICM with a positive predictive value of 100%. STV had the overall highest diagnostic accuracy. Results of the receiver operating characteristic curve are shown in Fig. [3](#Fig3){ref-type="fig"}. Intra and inter observer variability for STV measurement in ICM and NICM were good. The ICC values were 0.90 (95% CI 0.86--0.98), 0.92 (95% CI 0.90%--0.98) for intra observer variability and 0.84 (95% CI 0.78--0.88), 0.89 (95% CI 0.82--0.92) for inter-observer variability in ICM and NICM respectively.

Table 2Diagnostic test evaluation for select echocardiographic predictors of ischemic cardiomyopathySensitivity (%)Specificity (%)Positive predictive value (%)Negative predictive value (%)Accuracy (%)Segmental thickness variability (STV)79.1798.689593.7594Regional wall motion abnormality (RWMA)66.6784.2157.1488.8980STV or RWMA91.6782.8962.8696.9285STV and RWMA54.1710010087.3689Normal right ventricular size87.538.1630.8890.6350

Fig. 3Receiver operator curve analysis showing the performance of segmental thickness variability ratio from echocardiography to distinguish ischemic from non-ischemic dilated cardiomyopathy as confirmed by coronary angiogram

Discussion {#Sec5}
==========

Heart failure is a frequently diagnosed condition and a common cause of significant morbidity and mortality \[[@CR12]\]. A thorough initial work up to identify the underlying etiology can have prognostic and therapeutic implications. Certain phenotypes, like ICM, have higher mortality than other groups \[[@CR1], [@CR13], [@CR14]\].

To distinguish ICM from NICM, ACCF/AHA heart failure guidelines suggest that coronary angiogram be performed in patients presenting with de novo heart failure (Class IIA, level of evidence: C) \[[@CR15]\]. However, the use of angiography as a 'rule-out' tool has low diagnostic yield in these patients. Though ICM is the most prevalent form of dilated cardiomyopathy, the majority of these patients present with angina or myocardial infarction and only a few as de novo heart failure \[[@CR16], [@CR17]\]. In a study by Felker et al. among 1230 heart failure patients referred for endomyocardial biopsy, less than 10% were found to have ICM \[[@CR1], [@CR14]\]. In a recent study comparing MRI and angiography to distinguish ICM and NICM, ICM was reported in 22--26% of de novo HF patients \[[@CR18]\]. In the current study, we found ICM, as defined by angiogram, in 24% of new heart failure patients, falling within the general range of previously published data. Given this low incidence, finding a reliable pre-catheterization test to stratify patients based on likelihood of having ICM could prevent invasive testing in many. Low probability patients could instead be evaluated with a non-invasive modality (also a Class IIA recommendation) to exclude ischemic etiology.

In this study, we evaluated 18 clinical variables, 7 laboratory tests, 6 EKG parameters, and 13 echocardiographic markers with the goal of finding a diagnostic market that would reliably distinguish ICM from NICM (Table [1](#Tab1){ref-type="table"}). As expected, patients with ICM were significantly older mirroring the prevalence of CAD. They had more prevalent clinical risk factors like hypertension, diabetes and hyperlipidemia (with higher levels of total cholesterol and LDL). However, these differences did not reach statistical significance and thus were insufficient in providing classification advantage in the 100 patients studied. Similarly, EKG findings could not distinguish the two groups. These findings suggest that a pre-test probability evaluation for underlying coronary artery disease based on risk factor and clinical presentation may not be feasible in new heart failure patients.

Wall motion is a dynamic motion of the ventricular wall in systole and diastole that may be impaired by ischemia/infarction resulting in RWMAs. Wall thickness, on the other hand is more objective as measured at a single point in time, such as end systole or end-diastole. We measured end-diastolic wall thickness in this study as end-diastole represents true resting physiologic state of the myocardium. End-systolic measurement may be more prone for artefactual errors due to inclusion of the adjacent structures such as chordae and papillary muscle. Mechanisms of ischemic wall thinning are well described. Myocardial infarction causes myocyte necrosis and replacement with collagen scar resulting in thinning of the wall in the distribution of culprit coronary vessel \[[@CR19], [@CR20]\]. Similarly, in severe ischemia leading to hibernating myocardium, the wall in the affected territory thins out from loss of contractile elements and dedifferentiation, whereas surrounding segments may undergo compensatory hypertrophy and remodeling \[[@CR21]--[@CR24]\]. The resulting difference in segmental thickness is more obvious and may be unique to ICM and can be evaluated and interpreted as the STV ratio. We found an STV ratio of \< 0.65 to have excellent predictive value for ICM with 92% area under the curve (Fig. [1](#Fig1){ref-type="fig"}).

We systemically evaluated pre-angiographic non-invasive markers in new onset heart failure with dilated cardiomyopathy and found the presence of STV, RWMA, and normal RV size on echo to correspond to coronary vascular etiology. Among these parameters, STV by itself was the most sensitive and specific diagnostic marker of ICM with a predictive accuracy of 94%. Using STV in conjunction with RWMA could further increase the diagnostic test performance of STV. Visualization of either STV or RWMA could increase the sensitivity of identifying ICM, whereas the presence of both STV and RWMA in a patient made the test 100% specific for ICM. RV enlargement was found to be a sensitive but non-specific marker for NICM (Table [2](#Tab2){ref-type="table"}).

To our knowledge, this is the first study to report STV on echocardiography as a diagnostic marker of ICM. RWMA on the other hand has been studied previously, albeit with disparate findings \[[@CR4]--[@CR6]\]. In the current study, we found regional wall motion abnormalities to be 67% sensitive and 84% specific in diagnosing ICM. These differences highlight the subjective nature of wall motion analysis with significant inter-user variability. Additionally, it is widely known that RWMA can result not only from coronary ischemia but a number of other conditions such as primary myopericardial disease \[[@CR25]--[@CR29]\]. To increase specificity for ICM, we did not report septal abnormalities from right ventricular pressure/volume overload, left bundle branch block or ventricular pacing. Even still, RWMA was outperformed by STV.

Our study has a few limitations. The use of coronary angiography as the reference standard for distinguishing the cardiomyopathies may be a potential limitation. Further studies are needed to assess the reproducibility of this single center experience with a small number of patients and overcome potential reader bias in the interpretation of segmental wall analysis. Our study findings are not applicable to patients with suboptimal echo image quality from poor ultrasongraphic windows and technique. This may be overcome partially with the use of echocardiographic contrast agent. Prospective validation of this retrospective study would be desirable.

Conclusions {#Sec6}
===========

Dilated cardiomyopathy is a common disease process in patients presenting with new onset heart failure. In this patient population, STV as estimated by transthoracic echocardiography can accurately distinguish ICM from NICM. RWMA in isolation is a less accurate marker to make this distinction. Used in conjunction, these two parameters can reliably delineate ICM from NICM.

These echocardiographic markers to distinguish the underlying etiology of new onset heart failure may provide additional guidance to cardiac imagers and clinicians and guide appropriate therapy.
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